Athelas: Valuation, Funding & Investors
Athelas develops at-home diagnostic devices and clinical laboratory services to enable remote monitoring of patients, with a focus on point-of-care blood testing and digital health analytics. The company pairs compact capillary blood analyzers with cloud-based data and clinical workflows to deliver lab-grade results, support oncology and chronic disease management, and integrate results into care-team processes.
Leadership & Board
- Current Number of Employees
- 309
- Current LinkedIn Followers
- 30,274
Latest Estimated Valuation
- Total Amount Raised
- $59M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $59M
- Latest Funding Round
- Series C
Company Momentum
PositiveAthelas LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Athelas had 309 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Athelas had 30,274 followers as of November 2, 2026. The number of followers increased by 95 (0.31%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Mar 03, 2022 | Series C | $59.40M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Tribe Capital | Series C |
Similar Companies
A snapshot of private companies similar to Athelas, helping you discover and navigate related company profiles.
Related News and Analysis
